Geier, J; Lessmann, H; Hellweg, B et al.
Chromated metal products may be hazardous to patients with chromate allergyCONTACT DERMATITIS. Bd. 60. H. 4. 2009 S. 199-202
Trojandt, S; Wiechmann, N; Bovensiepen, C et al.
Comparative analysis of phenotypes and antigen presenting properties of differential stimulated human dendritic cellsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 379. 2009 S. 39-39
Besche, V.; Wiechmann, N.; Trojandt, S. et al.
Comparative analysis of the properties of murine DC`s genetically engineered to overexpress an panel of antiinflammatory moleculesEuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 330
Conrad, ML; Yildirim, AO; Sonar, SS et al.
Comparison of adjuvant and adjuvant-free murine experimental asthma models.Clin Exp Allergy. Bd. 39. H. 8. 2009 S. 1246-54
Sunderkotter, C; Herrgott, I; Bruckner, C et al.
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factorsBr J Dermatol. Bd. 160. H. 4. 2009 S. 835-43
Höhn, Y.; Renzing, A.; Montermann, E. et al.
Concurrent production of indoleamine-2,3-dioxygenase (IDO) after bilostic DNA vaccination inhibits initiation of transgene-specific immune responsesEuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 331-331
Schopf, R
Continuous treatment of a psoriasis patient with infliximab above 8 yearsJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 7. 2009 S. 193-193
Balkow, S; Loser, K; Krummen, M et al.
Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.Exp Dermatol. Bd. 18. H. 1. 2009 S. 78-87
Montermann, E.; Martin, H.; Grabbe, S. et al.
Determination of the tolerogenic potential of dexamethasone-treated antigen-presenting cells by in vivo MLREuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 652-652
von Stebut, E
Development of a vaccine for leishmaniasis - new from researchJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 7. 2009 S. 42-42